Chemists at Scripps Research in La Jolla say they have pulled off a bold molecular renovation of fentanyl, carving out its ...

Circle Pharma announced publication of research in the Journal of Medicinal Chemistry highlighting optimization of oral cyclin A/B RxL inhibitors.

Scientists at the University of Cambridge have developed a new way to alter complex drug molecules using light rather than ...

After years of research, international experts have confirmed the discovery of a new chemical reaction, launching new ...

Genentech has elected to stop a phase 2 trial of a RIPK1 inhibitor early and dump the asset after an analysis revealed the candidate was unlikely to meet the study’s primary endpoint. | Genentech has ...

A new “magic mushroom” compound may deliver psychedelic brain benefits without the trip.

New Advisors Bring 50+ Years of Leadership Experience With 2 of the Top 10 Global Pharmaceuticals CompaniesJericho, New York, March 11, 2026 ...

Psilocybin—the psychoactive compound in "magic mushrooms"—is gaining scientific attention for its potential in treating ...

Ten UMSL students presented diverse research projects to legislators during Undergraduate Research Day at the Missouri Capitol in Jefferson City on March 12.

Findings from two early clinical studies suggest a new dual-action antimalarial drug candidate is well tolerated in humans. The first-in-class clinical candidate, MK7602, is being developed by WEHI ...

The application of artificial intelligence (AI) in drug discovery is revolutionizing the field, offering unprecedented opportunities for accelerating the ...